J Cardiovasc Comput Tomogr. 2016 Jan-Feb;10(1):94-5. doi: 10.1016/j.jcct.2015.10.005. Epub 2015 Oct 30.
Leipsic JA1.
Since its introduction 25 years ago by Drs Agatston and Janowitz, coronary artery calcium scoring with computed tomography (CACS) has proven itself time and time again to be an extremely powerful risk stratification tool.1 The power of coronary calcium scoring to stratify risk has been shown in men and women, in young and old, and across diverse populations. Yet despite the reproducibility and robust nature of these findings CACS has seen only modest integration into clinical practice. The focus has largely been on the ability of CACS to identify those at an increased risk to intensify medical therapy.